From the Society of Nuclear Medicine meeting, an audio interview with Jeff Grenier, director of marketing and sales for Stockholm-based Hermes Medical Solutions, about the company’s plans for referring physician outreach and expansion into PACS.
For the past 30 years, Hermes Medical Solutions has been instrumental in connecting the myriad pieces that permit image postprocessing. At the 2006 Society of Nuclear Medicine meeting, Jeff Grenier, director of marketing and sales for Stockholm-based Hermes, explained how the company is extending its reach by distributing image fusion through licenses to referring physicians and others. It is the company's first foray into the PACS arena, as Hermes offers the software through the use of a server and archive. Hear in two minutes why this kind of sharing is critical.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
March 8th 2025The use of ultra-high-resolution photon-counting CT in the evaluation of stable chest pain may significantly reduce follow-up tests and invasive coronary angiography (ICA) procedures, possibly resulting in millions in health-care cost savings, according to a cost-effectiveness analysis presented recently at the European Congress of Radiology.